Let’s analyze the year passed
Main Article Content
Abstract
While we move ahead with the year 2009, let’s
devote some time analyzing the year ended. This
stock-taking is prudent to all the stakeholders of
AJP, particularly, as AJP still does not enjoy impact
factor ratings.
devote some time analyzing the year ended. This
stock-taking is prudent to all the stakeholders of
AJP, particularly, as AJP still does not enjoy impact
factor ratings.
Article Details
Section
Articles
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
How to Cite
Let’s analyze the year passed. (2014). Asian Journal of Pharmaceutics (AJP), 3(1). https://doi.org/10.22377/ajp.v3i1.300